Miniature pig

FBN® Partners with Boveta Nutrition™ to Launch Proprietary Feeding System for Beef Cattle to Reduce Feeding Costs in the Beef Industry

Retrieved on: 
Friday, January 27, 2023
Diet, Health, Farmers Business Network, Nutrient, Agtech, Farmer, Cattle, Livestock, Economic Research Service, Milk, Meat, FBN, Miniature pig, SAN, Methane, Animal nutritionist, United Soybean Board, Environment, Poultry, Animal husbandry, Feed manufacturing

Plus, the health of the cattle and their overall performance has gone up greatly,” says Row.

Key Points: 
  • Plus, the health of the cattle and their overall performance has gone up greatly,” says Row.
  • A team of experienced FBN nutritionists, led by Dr. Monty Kerley, will help bring the industry-leading system to the market.
  • We’re thrilled to be partnering with Boveta to help change the beef feed industry," says Luiz Beling, president of FBN Direct.
  • According to the USDA Economic Research Service, prices for beef cattle feed were up 16% in May 2022 relative to May 2021.

Insights on the Livestock Insurance Global Market to 2031 - Surge in Number of Diseases in Livestock Animals Drives Growth

Retrieved on: 
Tuesday, January 17, 2023
Animal, Livestock, Cattle, ICICI Lombard, Horse, Hub International, Insurance, Fever, Benchmarking, Porter's five forces analysis, Miniature pig, Death, Government, Major, Poultry, Risk, JLG Industries, AXA SA, Smoke, AXA, FBL Financial Group, Growth, Application, Graupel, Phil, Farmer, Nationwide Mutual Insurance Company, Joint Liability Groups, HDFC, Bancassurance, Market share, Earthquake, Retail, Agriculture

Surge in number of diseases in livestock animals including flu, ringworms, fever and others, has led to rise in purchase of livestock insurance among farmers and livestock owners.

Key Points: 
  • Surge in number of diseases in livestock animals including flu, ringworms, fever and others, has led to rise in purchase of livestock insurance among farmers and livestock owners.
  • However, many small scale farmers in rural areas cannot afford livestock insurance, due to high rate of premiums, which is a major drawback for the livestock insurance market.
  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the livestock insurance market analysis from 2021 to 2031 to identify the prevailing livestock insurance market opportunities.
  • The report includes the analysis of the regional as well as global livestock insurance market trends, key players, market segments, application areas, and market growth strategies.

AGCO Brands Win Ten 2023 AE50 Awards

Retrieved on: 
Tuesday, December 13, 2022
Other Manufacturing, Technology, Agritech, Chemicals, Plastics, Manufacturing, Software, Machinery, Agriculture, Natural Resources, Cloud, Intelligence, Agriculture, Society, HP, CTF, IPad, CEA, Database, Food, Massey, GPS, Soil, BXM, Manure, NYSE, CO2, Reclaim, Vario, Water, Multimedia, AP, Fuse, Bachelor of Engineering, Controlled traffic farming, Farmer, CVT, Data management, Agitation, Noise, Compressed air, AGCO, Miniature pig, HD, TWA, Precision, ASABE, Automation, TIM, Pressure, Heavy equipment

AGCO Corporation (NYSE: AGCO), a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology, received ten AE50 Awards from the American Society of Agricultural and Biological Engineers (ASABE) for 2023.

Key Points: 
  • AGCO Corporation (NYSE: AGCO), a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology, received ten AE50 Awards from the American Society of Agricultural and Biological Engineers (ASABE) for 2023.
  • AGCOs ten AE50 awards span the companys strong brand portfolio, including Fendt, Fuse, Intelligent Ag, Massey Ferguson, and Precision Planting.
  • View the full release here: https://www.businesswire.com/news/home/20221213005076/en/
    AGCO Corp. won ten 2023 AE50 Awards from ASABE for innovative design in engineering products or systems for agriculture.
  • AGCO delivers customer value through its differentiated brand portfolio including core brands like Challenger, Fendt, GSI, Massey Ferguson, Precision Planting and Valtra.

Fishmeal & Fish Oil Global Market Report 2022: Increasing Awareness About Livestock and Pet Health and Nutrition Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, December 5, 2022
Food, Beverage, Retail, Salmon, PETS, Salmon-Trout, Poultry, Animal, Digestion, Application server, Aquaculture, Miniature pig, Nutrient, Livestock, Absorption, Tilapia, Growth, Fish meal, Health, Traction, Region, USD, Cattle, Carp, Pet, Domestic pig

The "Fishmeal & Fish Oil Market by Type (Fishmeal, Fish Oil), Source (Salmon & Trout, Marine Fish, Crustaceans, Tilapia, Carps), Livestock Application (Aquatic Animals, Swine, Poultry, Cattle, Pets), Industrial Application & Region - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Fishmeal & Fish Oil Market by Type (Fishmeal, Fish Oil), Source (Salmon & Trout, Marine Fish, Crustaceans, Tilapia, Carps), Livestock Application (Aquatic Animals, Swine, Poultry, Cattle, Pets), Industrial Application & Region - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
  • According to the publisher, the global fishmeal & fish oil market is estimated to be valued at USD 12.1 billion in 2022.
  • The market is gaining momentum as fishmeal & fish oil continue to find increased applications across various livestock and industrial applications.
  • Additionally, the rising innovation in the fishmeal & fish oil market and technological advancements which are enhancing the efficiency of fishmeal & fish oil have contributed to the growth of the market in recent years.

Feed Mycotoxin Binders And Modifiers Global Market Report 2022: Ukraine-Russia War Impact

Retrieved on: 
Tuesday, December 6, 2022
ZEN, BASF SE, Silage, SE, Triticale, Poultry, Infection, Mycotoxin, Bayer, Associated British Foods, Animal, Fungus, ADM (company), Ruminant, Miniature pig, Breeding, Alltech, Livestock, Absorption, COVID-19, Risk, BASF, Catastrophic injury, Kemin Industries, Acquisition, Organization, Renewable energy, Pig

The feed mycotoxin binders and modifiers market is expected to grow to $ 2.79 billion in 2026 at a CAGR of 4.3%.

Key Points: 
  • The feed mycotoxin binders and modifiers market is expected to grow to $ 2.79 billion in 2026 at a CAGR of 4.3%.
  • The feed mycotoxin binders and modifiers consist of sales feed mycotoxin binders and modifiers by entities (organizations, sole traders, partnerships) that are used to trap mycotoxins, keeping them from entering the bloodstream and causing catastrophic injury to animals.The feed mycotoxin binders and modifiers are feed additives that are added to feed to prevent mycotoxins absorption through the gut and entry into the bloodstream.
  • The main types of feed mycotoxin binders and modifiers are feed mycotoxin binders and feed mycotoxin modifiers.Feed mycotoxin binders are most widely used in the dry form because they mix readily with the feed ingredients and are easy to store.
  • The feed mycotoxin binders and modifiers market research report is one of a series of new reports that provides feed mycotoxin binders and modifiers market statistics, including feed mycotoxin binders and modifiers industry global market size, regional shares, competitors with feed mycotoxin binders and modifiers market share, detailed feed mycotoxin binders and modifiers market segments, market trends, and opportunities, and any further data you may need to thrive in the feed mycotoxin binders and modifiers industry.

Bachoco Reaches an Agreement to Acquire Norson, in Mexico

Retrieved on: 
Friday, December 2, 2022
Retail, Agriculture, Natural Resources, Food, Beverage, NYSE, HR, New York Stock Exchange, Egg, AAA, IBA, C.V, BMV, Miniature pig, Genetics, MEX, Investment, Guanajuato, Protein, S.A, Poultry

de C.V. (Bachoco or the Company) (NYSE: IBA; BMV: BACHOCO), announced today that it has achieved a business agreement to acquire 100% of the capital equity of Norson Holding S. de R.L.

Key Points: 
  • de C.V. (Bachoco or the Company) (NYSE: IBA; BMV: BACHOCO), announced today that it has achieved a business agreement to acquire 100% of the capital equity of Norson Holding S. de R.L.
  • With more than 40 years of presence in the market, Norson is a relevant pork producer in Mexico.
  • This agreement is in line with our growth plans for our pork business and follows our diversification strategy in other proteins.
  • Bachoco is a vertically integrated Company headquartered in Celaya, Guanajuato located in Central Mexico.

Amlan International Adds Sales Manager, Distribution Partner and is Granted New Registration of Calibrin-Z in the Philippines

Retrieved on: 
Tuesday, November 29, 2022
Poultry, COVID-19, Jayson, Agriculture, ODC, Government, Livestock, Kingdom, NYSE, Peanut Corporation of America, Health, Miniature pig, Animal, Toxin, Feed manufacturing

Jayson Fernandez joined Amlan as a sales manager for the Philippines in January 2022 and FJ Wegon Animal Health and Nutrition Inc. is now registered to distribute proven biotoxin binder Calibrin-Z.

Key Points: 
  • Jayson Fernandez joined Amlan as a sales manager for the Philippines in January 2022 and FJ Wegon Animal Health and Nutrition Inc. is now registered to distribute proven biotoxin binder Calibrin-Z.
  • Registration is pending of additional high-value feed additives, such as patented Varium, designed for poultry feed efficiency.
  • Oil-Dri Corporation of America doing business as Amlan International is a publicly traded stock on the New York Stock Exchange (NYSE: ODC).
  • Product availability may vary by country, associated claims do not constitute medical claims and may differ based on government requirements.

Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results

Retrieved on: 
Monday, November 14, 2022
Universe, Result, Sale, Blood, Trial of the century, Analysis, GlobalData, Ulcerative colitis, Syringe, Therapy, Patent, Patient, American College, DNA, Conference, Precision medicine, GI, Athyrium, Miniature pig, Research, Safety, Financial condition report, Disease, Parenteral Drug Association, Annual report, Adalimumab, Hand, Serri, Sardinia, American College of Gastroenterology, COVID-19, Colon, Comparison, SAN, Webcast, Roche Diagnostics, Medical device, Security (finance), Fine chemical, Pharmaceutical industry, Renewable energy, Motor vehicle, Reinsurance

Presented results of human study at the American College of Gastroenterology annual meeting, demonstrating promising device performance in active ulcerative colitis patients

Key Points: 
  • Presented results of human study at the American College of Gastroenterology annual meeting, demonstrating promising device performance in active ulcerative colitis patients
    SAN DIEGO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today provided a corporate update and reported financial results for the third quarter ended September30, 2022.
  • Biora also shared preclinical results from its systemic therapeutics program, demonstrating promising device performance using liquid jet injection to the small intestine in animal models.
  • Biora Therapeutics will host a webcast and conference call to discuss the third quarter financial results and answer investment community questions today, Monday, November 14, 2022 at 4:30 p.m. Eastern / 1:30 p.m. Pacific.
  • Biora Therapeutics expressly disclaims any obligation to update any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law.

Ainos Publishes Preclinical Data Demonstrating its VELDONA Formulation's Potential as Treatment Candidates for the Most Common Medical Conditions for Companion Animals

Retrieved on: 
Monday, November 21, 2022
SAN, VOC, POCT, Growth, RATS, Miniature pig, Mouse, Plasma protein binding, Feline coronavirus, Ciclosporin, Dog, Immunity, Therapy, Animal, Risk, Cat, Research, Saudi Research and Marketing Group, Cattle, Acceleration, US, EC50, Sale, Volatile organic compound, Market, Point-of-care testing, Roy Taylor (scientist), Guinea, Annual report, Subclinical infection, Horse, COVID-19, Human, AIMD, CAD, Prevalence, FCGS, Pharmaceutical industry, Vaccine, Pet, Ainos

SAN DIEGO, Nov. 21, 2022 /PRNewswire/ -- Ainos, Inc. (NASDAQ: AIMD, AIMDW) ("Ainos", or the "Company"), a diversified medtech company focused on the development of novel point-of-care testing, low-dose interferon therapeutics, and synthetic RNA-driven preventative medicine, today announced that it has published preclinical data demonstrating the potential of its low-dose oral interferon-alpha (IFNα) formulation, VELDONA®, as treatment candidates for the two most common medical conditions for dogs and cats. The preclinical data can be accessed here.

Key Points: 
  • The Company initially applied VELDONA to feline coronavirus (FCoV)-infected fcwf-4 (feline microphage) systems to determine potency and dose translation.
  • Based on VELDONA's effective antiviral efficacy,the Company is planning an expansion of its use for the treatment of humans to treatment of animals.
  • Ainos is designing dose-finding field studies to identify optimal VELDONA dose via oromucosal administration for feline FCGS and canine CAD.
  • FCGS is a severe oral mucosal inflammatory disease afflicting cats, while CAD is an inflammatory skin disease found in dogs.

Neogen® Launches Synergize® Disinfectant in Europe, the Middle East, Africa

Retrieved on: 
Tuesday, November 15, 2022
Foam, Drug, Animal testing, Gram-positive bacteria, European, Miniature pig, Spore, Intention, Adenosine triphosphate, Solution, Minister for Rural Affairs (United Kingdom), Animal, Livestock, Synergy, Food safety, Health Canada, ATP, Food chain, Biophysical environment, Cattle, Fungus, Poultry, Disinfectant, NASDAQ, Plant, CEO, Virus, Food, Medium (website), Neogen, Pick-up sticks, Disease, Bottled water, Sewage

LEXINGTON, Ky., Nov. 15, 2022 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it has launched its trusted Synergize® disinfectant in Europe, the Middle East, and Africa.

Key Points: 
  • LEXINGTON, Ky., Nov. 15, 2022 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it has launched its trusted Synergize disinfectant in Europe, the Middle East, and Africa.
  • "Our Synergize disinfectant has long been trusted in North America to protect people and animals," said John Adent, Neogen's President and CEO.
  • Synergize disinfectant is a combination quaternary ammonium and glutaraldehyde multi-purpose disinfectant that is non-corrosive to hard surfaces, killing both Gram-negative and Gram-positive bacteria, fungi, spores, and viruses.
  • Synergize will be launched at the EuroTier exhibition this week in Hannover, Germany, where Neogen will exhibit its full range of biosecurity solutions in Hall 23 D47.